[The intestinal microbiota: a boost for antitumor treatments]
- PMID: 24801040
- DOI: 10.1051/medsci/20143004019
[The intestinal microbiota: a boost for antitumor treatments]
Abstract
Two new studies in mice, published in Science, show that the commensal bacteria populations in the gut play a key role in boosting responses to different antitumor regimens. These results argue for a rational use of antibiotics when managing infections in patients undergoing cancer therapies.
© 2014 médecine/sciences – Inserm.
Similar articles
-
Gut microbiota: Anti-cancer therapies affected by gut microbiota.Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):1. doi: 10.1038/nrgastro.2013.238. Epub 2013 Dec 10. Nat Rev Gastroenterol Hepatol. 2014. PMID: 24322902 No abstract available.
-
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.Science. 2013 Nov 22;342(6161):967-70. doi: 10.1126/science.1240527. Science. 2013. PMID: 24264989 Free PMC article.
-
Biomedicine. Cancer therapies use a little help from microbial friends.Science. 2013 Nov 22;342(6161):921. doi: 10.1126/science.342.6161.921. Science. 2013. PMID: 24264971 No abstract available.
-
[The role of intestinal microbiota in the response to anti-tumor therapies].Med Sci (Paris). 2016 Nov;32(11):974-982. doi: 10.1051/medsci/20163211013. Epub 2016 Dec 23. Med Sci (Paris). 2016. PMID: 28008838 Review. French.
-
Gut microbiome and anticancer immune response: really hot Sh*t!Cell Death Differ. 2015 Feb;22(2):199-214. doi: 10.1038/cdd.2014.56. Epub 2014 May 16. Cell Death Differ. 2015. PMID: 24832470 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources